查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1716839

临床试验配对软体市场（按功能、部署和应用）—2025 年至 2030 年全球预测

Clinical Trials Matching Software Market by Functionality, Deployment, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

临床试验匹配软体市场规模在 2023 年估计为 3.422 亿美元，预计到 2024 年将增长至 3.8689 亿美元，复合年增长率为 13.54%，预计到 2030 年将达到 8.3256 亿美元。

主要市场统计数据
基准年2023年 3.422亿美元
预计2024年 3.8689亿美元
预测年份 2030 8.3256亿美元
复合年增长率（%） 13.54%

临床试验比以往任何时候都更加动态，促进患者配对和简化资料管理的软体解决方案是研究环境中的关键资产。在过去几年中，创新技术的激增以及对精准医疗的日益重视重塑了组织进行临床研究的方式。对强大的分析、即时彙报和安全数据管理的需求正在推动市场呈上升趋势。该行业的相关人员意识到传统方法已不足以应对不断加快的计划时程和监管要求。本介绍分析深入探讨了定义下一代临床试验配对软体的技术进步和产业趋势。讨论揭开这些变化背后的故事，包括全面的細項分析、区域评估、对关键行业参与者的洞察等，以便更清楚地了解这个不断发展的市场中的未来机会和挑战。

技术与临床科学的结合不仅仅是操作的升级。必须认识到这些技术创新对缩短临床试验时间同时提高法规遵循和数据准确性的影响。

改变临床试验匹配软体市场

近年来，随着组织转向更整合、数据主导的解决方案，临床试验配对软体市场发生了变革。云端技术、人工智慧和机器学习的进步正在重新定义临床试验生态系统的功能和效率。市场参与企业正在利用先进的分析技术，不仅可以加快数据报告速度，还可以更准确地预测患者配对结果。这一演变是由对资料完整性、合规性和大型资料集高效管理的坚定承诺所推动的。

合规追踪和报告领域明显转向利用数位工具，创新者实施系统来无缝管理复杂的监管要求。自动化最大限度地减少了人工错误并提高了资料处理速度。融合区块链等最尖端科技以确保资料安全，以及分散式帐本系统以确保透明度，正逐渐成为标准做法。此外，增强的工具透过支援可扩展性和适应性提供了竞争优势，允许组织定制系统以满足其独特的研究需求。

这项变革性的演化步骤为未来的改进奠定了基础，其中即时分析和预测模型将发挥关键作用，推动决策改进和临床试验时间表加速的时代。

临床试验匹配软体市场的关键细分洞察

在研究临床试验匹配软体市场时，细分提供了了解产业需求复杂性的关键见解。市场细分是按功能进行的，捕捉专注于分析和彙报、合规性追踪、数据管理和患者匹配的解决方案之间的差异。按功能细分反映了相关人员不断变化的需求，他们寻求整合解决方案，不仅可以处理数据，还可以提供简化临床研究业务的预测见解。同样，基于部署的细分也很重要，市场分为基于云端/网路的解决方案和内部部署系统。这种差异凸显了人们对灵活、扩充性的基于 SaaS 的平台的日益偏好，这些平台可以根据不断变化的研究需求快速部署。

另一个重要的细分是围绕最终用户群，其中包括受託研究机构、医疗设备公司、製药公司和生物技术公司。每个最终用户群体都面临着独特的挑战并有不同的营运要求。详细分类强调了需要客製化软体选项来应对这些不同的挑战。这种细分洞察提供了对市场动态的详细了解，并为专业化和强大的解决方案铺平了道路。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 增加临床试验活动并专注于提高患者的可及性
      • 医疗保健领域对虚拟测试和自动化的潜在需求
    • 限制因素
      • 对配对软体准确性的担忧
    • 机会
      • 充满活力的Start-Ups生态系统和大量软体开发资金
      • 精准医疗临床试验中临床试验配对解决方案的巨大潜力
    • 任务
      • 缺乏熟练且经验丰富的专业人员以及对资料管理的担忧
  • 市场区隔分析
    • 功能：利用分析、合规性和患者匹配来优化效率和多功能性
    • 最终用途：合约研究组织中的多种应用，实现无缝资料流
    • 部署：扩展云端基础的临床试验匹配软体部署，实现可扩展性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 临床试验配对软体市场（按功能）

  • 分析和报告
  • 合规性追踪
  • 资料管理
  • 患者匹配

第七章临床试验配对软体市场（按部署）

  • 基于云端和 Web
  • 本地

8. 临床试验配对软体市场（依最终用途）

  • CRO
  • 医疗设备公司
  • 製药和生物技术公司

9.美洲临床试验配对软体市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

10. 亚太临床试验配对软体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第 11 章欧洲、中东和非洲临床试验配对软体市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023年市场占有率分析
  • 2023年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Advarra, Inc.
  • Antidote Technologies, Inc.
  • AQ, Inc
  • AutoCruitment LLC
  • BBK Worldwide, LLC by Publicis Health company
  • BEKhealth Corporation
  • Belongtail Ltd.
  • Carebox Healthcare Solutions, Inc.
  • Clara Health by M&B Sciences Inc：
  • Clariness GmbH
  • Clario
  • ClinicalConnection, Inc.
  • CSSi
  • Deep 6 AI Inc.
  • Elligo Health Research, Inc.
  • Evidation Health, Inc.
  • Formation Bio, Inc.
  • HCL Technologies Limited
  • HealthMatch Pty. Ltd.
  • ICON plc
  • Inato
  • Inspirata, Inc.
  • International Business Machines Corporation
  • IQVIA Holdings Inc.
  • Lokavant, Inc.
  • Medable Inc.
  • Medidata by Dassault Systemes SE
  • Medocity, Inc.
  • Microsoft Corporation
  • Parexel International Corporation
  • PatientWing
  • Science 37, Inc. by eMed, LLC
  • Science4Tech Solutions, SL
  • Sumatosoft LLC
  • Syneos Health, Inc.
  • Teckro, Inc.
  • Tempus Labs, Inc.
  • Trialbee AB
  • TrialHub by FindMeCure Ltd.
  • Veeva Systems Inc.
  • Worldwide Clinical Trials
Product Code: MRR-8C74ADFBFDF8

The Clinical Trials Matching Software Market was valued at USD 342.20 million in 2023 and is projected to grow to USD 386.89 million in 2024, with a CAGR of 13.54%, reaching USD 832.56 million by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 342.20 million
Estimated Year [2024] USD 386.89 million
Forecast Year [2030] USD 832.56 million
CAGR (%) 13.54%

Clinical trials have never been more dynamic, and software solutions that facilitate patient matching and streamline data management have become critical assets in the research landscape. Over the past few years, the surge in innovative technologies coupled with an increased emphasis on precision medicine has reshaped the way organizations approach clinical research. The market has witnessed an upward trend driven by the demand for robust analytics, real-time reporting, and secure data management. Stakeholders in the sector have recognized that traditional methodologies are no longer sufficient to cope with accelerating project timelines and regulatory demands. This introductory analysis sets the stage for a deep dive into the technological advancements and industry trends that are defining the next generation of clinical trials matching software. As we unfold the story behind these changes, the discussion will encompass comprehensive segment analyses, regional evaluations, and insights on key industry players-all of which contribute to a clearer understanding of future opportunities and challenges in this evolving market.

The fusion of technology with clinical science is not just an operational upgrade-it is a transformative evolution that is improving patient outcomes and operational efficiency. It is essential to recognize the impact of these innovations on reducing trial timelines while ensuring enhanced regulatory compliance and data accuracy.

Transformative Shifts in the Clinical Trials Matching Software Landscape

Recent years have seen transformative shifts in the clinical trials matching software market as organizations pivot towards more integrated, data-driven solutions. Advances in cloud technology, artificial intelligence, and machine learning have redefined the functionalities and efficiencies within the clinical trials ecosystem. Market participants are harnessing advanced analytics to not only accelerate data reporting but also to predict patient matching outcomes with greater precision. This evolution is driven by an unwavering commitment to data integrity, compliance, and the efficient management of large datasets.

A marked shift towards leveraging digital tools in the realm of compliance tracking and reporting is evident, with innovators introducing systems that seamlessly manage complex regulatory requirements. Automation has minimized manual errors and increased the speed of data processing. The integration of cutting-edge technologies like blockchain for data security and distributed ledger systems for ensuring transparency is gradually becoming standard practice. Furthermore, enhanced tools provide a competitive edge by supporting scalability and adaptability, making it possible for organizations to customize their systems to suit unique research needs.

This stage of transformative evolution is laying the groundwork for future enhancements where real-time analytics and predictive modeling will play pivotal roles, driving an era of improved decision-making and accelerated clinical trial timelines.

Key Segmentation Insights in the Clinical Trials Matching Software Market

In examining the clinical trials matching software market, segmentation provides critical insight into the intricacies of industry demand. The market is segmented on functionality, capturing differences in solutions focused on analytics and reporting, compliance tracking, data management, and patient matching. Such a functional breakdown reflects the evolving needs of stakeholders who demand integrated solutions that not only handle data but also offer predictive insights which streamline clinical research operations. Equally telling is the segmentation based on deployment, with the market divided between cloud and web-based solutions versus on-premise systems. This distinction highlights the growing preference for flexible, scalable software as a service platforms that can be rapidly deployed to meet changing research needs.

Another pivotal segmentation concerns end-use demographics, encompassing contract research organizations, medical device firms, as well as pharmaceuticals and biotechnology companies. Each end-user group faces unique challenges and has different operational requirements. The detailed breakdown underscores the necessity for tailored software options that address these diverse challenges. This segmentation insight offers a granular understanding of market dynamics, paving the way for solutions that are both specialized and robust.

Based on Functionality, market is studied across Analytics & Reporting, Compliance Tracking, Data Management, and Patient Matching.

Based on Deployment, market is studied across Cloud & Web Based and On-Premise.

Based on End-Use, market is studied across CROs, Medical Device Firms, and Pharmaceuticals & Biotechnology Companies.

Key Regional Insights Shaping the Global Market

Regional dynamics play a significant role in the evolution of the clinical trials matching software market. In the Americas, technology adoption is spurred by an integrated healthcare system and robust funding for research and development, leading to swift integration of modern software solutions into clinical operations. Meanwhile, the region encompassing Europe, the Middle East, and Africa shows a blend of regulatory complexities and growing tech adoption that is fueling demand for highly secure and compliant systems. Regulatory frameworks in these regions necessitate advanced software solutions that not only secure data but also ensure real-time compliance with local and international standards.

In the Asia-Pacific, rapid economic growth, coupled with an expanding healthcare sector and increasing investments in clinical research, is driving demand for innovative matching software. The diversity in healthcare ecosystems throughout the region encourages developers to localize and customize solutions to meet varied operational requirements. Overall, these regional insights provide a broad perspective on technological adoption trends and clarify how localized challenges and market needs are steering the global clinical trials matching software landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Perspectives and Competitive Landscape

The market's competitive landscape is characterized by a myriad of players who have invested substantially in enhancing the clinical trials matching software portfolio. Industry leaders-such as Advarra, Inc., Antidote Technologies, Inc., AQ, Inc, and AutoCruitment LLC-are actively driving innovation by integrating advanced analytics, seamless data integration, and compliance-focused functionalities into their offerings. In addition, companies like BBK Worldwide, LLC by Publicis Health company, BEKhealth Corporation, and Belongtail Ltd. have carved out niches by focusing on specific technological capabilities and expanding their deployment models.

Furthermore, innovators including Carebox Healthcare Solutions, Inc., Clara Health by M&B Sciences Inc, Clariness GmbH, and Clario are spearheading development efforts that push the boundaries of traditional software functionalities. ClinicalConnection, Inc., CSSi, Deep 6 AI Inc., Elligo Health Research, Inc., Evidation Health, Inc., and Formation Bio, Inc. have contributed to an environment where continuous improvement is the norm. With additional contributions from industry giants such as HCL Technologies Limited, HealthMatch Pty. Ltd., ICON plc, and Inato, the market has evolved into a robust ecosystem. Other key players like Inspirata, Inc., International Business Machines Corporation, IQVIA Holdings Inc., Lokavant, Inc., Medable Inc., Medidata by Dassault Systemes SE, Medocity, Inc., Microsoft Corporation, Parexel International Corporation, PatientWing, Science 37, Inc. by eMed, LLC, Science4Tech Solutions, S.L., Sumatosoft LLC, Syneos Health, Inc., Teckro, Inc., Tempus Labs, Inc., Trialbee AB, TrialHub by FindMeCure Ltd., Veeva Systems Inc., and Worldwide Clinical Trials continue to shape market expectations through both innovation and strategic investments.

Their combined efforts are setting new benchmarks for performance, scalability, and compliance, underscoring the market's dynamic nature and the potential for further evolution.

The report delves into recent significant developments in the Clinical Trials Matching Software Market, highlighting leading vendors and their innovative profiles. These include Advarra, Inc., Antidote Technologies, Inc., AQ, Inc, AutoCruitment LLC, BBK Worldwide, LLC by Publicis Health company, BEKhealth Corporation, Belongtail Ltd., Carebox Healthcare Solutions, Inc., Clara Health by M&B Sciences Inc:, Clariness GmbH, Clario, ClinicalConnection, Inc., CSSi, Deep 6 AI Inc., Elligo Health Research, Inc., Evidation Health, Inc., Formation Bio, Inc., HCL Technologies Limited, HealthMatch Pty. Ltd., ICON plc, Inato, Inspirata, Inc., International Business Machines Corporation, IQVIA Holdings Inc., Lokavant, Inc., Medable Inc., Medidata by Dassault Systemes SE, Medocity, Inc., Microsoft Corporation, Parexel International Corporation, PatientWing, Science 37, Inc. by eMed, LLC, Science4Tech Solutions, S.L., Sumatosoft LLC, Syneos Health, Inc., Teckro, Inc., Tempus Labs, Inc., Trialbee AB, TrialHub by FindMeCure Ltd., Veeva Systems Inc., and Worldwide Clinical Trials. Actionable Recommendations for Industry Leaders

Decision-makers in the clinical trials matching software market should consider a multi-faceted strategy to maintain competitive advantage. First, investing in scalable, cloud-based solutions that offer real-time data analytics and predictive capabilities is essential. Organizations are encouraged to integrate automation into compliance tracking and reporting functions to reduce manual errors and expedite the trial process. It is also advisable to continuously update software capabilities to cope with evolving regulatory standards, ensuring that systems remain secure and robust against cyber threats.

Moreover, companies should foster strategic partnerships and invest in research and development to fuel innovation. Embracing a customer-centric approach-one that customizes functionalities based on specific research needs-can drive higher adoption rates and improve trial outcomes. Leveraging advanced analytics to interpret large datasets and monitor key performance metrics will enable leaders to make informed decisions that streamline operations. Finally, keeping abreast of regional regulatory changes and ensuring that software solutions are flexible enough to adapt to local market demands can unlock new market opportunities and enhance overall service delivery.

Conclusion and Future Outlook

In summary, the clinical trials matching software market is making significant strides toward enhanced efficiency, data precision, and regulatory compliance. The integration of advanced technologies such as AI and cloud services has revolutionized the market landscape by enabling faster, more accurate patient matching and comprehensive data management. The segmentation of the market across functionality, deployment, and end-use highlights the diverse needs of stakeholders, and the favorable regional trends reinforce the global momentum behind digital transformation in clinical research. Furthermore, the competitive landscape driven by key industry participants reflects a sustained commitment to innovation and excellence.

As the market continues to mature, stakeholders must remain vigilant and proactive in adapting to rapid changes. This evolving environment offers significant opportunities for organizations to harness new technologies, streamline processes, and ultimately drive better clinical outcomes. The continued evolution of these software solutions will be instrumental in addressing the complex challenges faced by today's clinical research landscape, paving the way for a more integrated and efficient future.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising clinical trial activities and emphasis on improved patient availability
      • 5.1.1.2. Potential demand for virtual trials and automation in the healthcare sector
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with the accuracy of matching software
    • 5.1.3. Opportunities
      • 5.1.3.1. Vibrant startup ecosystem and significant funding for software developments
      • 5.1.3.2. High potential of clinical trial matching solutions for precision medicine clinical trials
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled and experienced professionals and data management concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Functionality: Leveraging analytics, compliance, and patient matching for optimal efficiency and diversity
    • 5.2.2. End-Use: Diverse scope of applications in contract research organizations for seamless data flow
    • 5.2.3. Deployment: Increasing cloud based deployment of clinical trials matching software for scalability
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trials Matching Software Market, by Functionality

  • 6.1. Introduction
  • 6.2. Analytics & Reporting
  • 6.3. Compliance Tracking
  • 6.4. Data Management
  • 6.5. Patient Matching

7. Clinical Trials Matching Software Market, by Deployment

  • 7.1. Introduction
  • 7.2. Cloud & Web Based
  • 7.3. On-Premise

8. Clinical Trials Matching Software Market, by End-Use

  • 8.1. Introduction
  • 8.2. CROs
  • 8.3. Medical Device Firms
  • 8.4. Pharmaceuticals & Biotechnology Companies

9. Americas Clinical Trials Matching Software Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Clinical Trials Matching Software Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Trials Matching Software Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Massive Bio and UICC Partner to Revolutionize Cancer Research with AI-Driven Clinical Trial Matching
    • 12.3.2. Parexel and Palantir Expand Partnership to Enhance Clinical Trial Efficiency and Patient Outcomes
    • 12.3.3. Trialbee and Massive Bio Team Up to Enhance Oncology Clinical Trial Participation Using Advanced Patient-Matching Technology
    • 12.3.4. Deep 6 AI and Graticule Partner to Accelerate Clinical Trial Recruitment and Enhance Public Health
    • 12.3.5. Medable and Pluto Health Partner to Enhance Clinical Trial Matching and Patient Engagement
    • 12.3.6. Belong.life Launches AI SaaS to Simplify Cancer Trial Matching and Boost Enrollment
    • 12.3.7. Tempus Acquires Mpirik to Enhance Clinical Trial Matching and Drive Personalized Medicine Advancements
    • 12.3.8. Tempus Unveils TAAP Platform to Revolutionize Clinical Trials with AI-Powered Diagnostics and Enhanced Data Analytics
    • 12.3.9. Texas Tech University Health Sciences Center Partners with Deep 6 AI to Enhance Efficiency in Clinical Trial Matching
    • 12.3.10. Caris Life Sciences and ConcertAI Collaborate to Revolutionize Clinical Trial Matching for Cancer Patients
    • 12.3.11. Carebox Introduces Carebox Connect to Improve Participant Diversity
    • 12.3.12. Pfizer and Tempus Labs Inc. Partnered to Revolutionize Clinical Trials through AI-Driven Precision Medicine
    • 12.3.13. Paradigm Secures USD 203 million to Enhance Clinical Trials Matching Software and Streamline Recruitment Process
    • 12.3.14. Science4Tech Secures EUR 2 Million Funding to Transform Cancer Trials with Innovative MatchTrial Platform
  • 12.4. Strategy Analysis & Recommendation
    • 12.4.1. Medidata by Dassault Systemes SE
    • 12.4.2. Science 37, Inc. by eMed, LLC
    • 12.4.3. International Business Machines Corporation
    • 12.4.4. AutoCruitment LLC
    • 12.4.5. Deep 6 AI Inc.

Companies Mentioned

  • 1. Advarra, Inc.
  • 2. Antidote Technologies, Inc.
  • 3. AQ, Inc
  • 4. AutoCruitment LLC
  • 5. BBK Worldwide, LLC by Publicis Health company
  • 6. BEKhealth Corporation
  • 7. Belongtail Ltd.
  • 8. Carebox Healthcare Solutions, Inc.
  • 9. Clara Health by M&B Sciences Inc:
  • 10. Clariness GmbH
  • 11. Clario
  • 12. ClinicalConnection, Inc.
  • 13. CSSi
  • 14. Deep 6 AI Inc.
  • 15. Elligo Health Research, Inc.
  • 16. Evidation Health, Inc.
  • 17. Formation Bio, Inc.
  • 18. HCL Technologies Limited
  • 19. HealthMatch Pty. Ltd.
  • 20. ICON plc
  • 21. Inato
  • 22. Inspirata, Inc.
  • 23. International Business Machines Corporation
  • 24. IQVIA Holdings Inc.
  • 25. Lokavant, Inc.
  • 26. Medable Inc.
  • 27. Medidata by Dassault Systemes SE
  • 28. Medocity, Inc.
  • 29. Microsoft Corporation
  • 30. Parexel International Corporation
  • 31. PatientWing
  • 32. Science 37, Inc. by eMed, LLC
  • 33. Science4Tech Solutions, S.L.
  • 34. Sumatosoft LLC
  • 35. Syneos Health, Inc.
  • 36. Teckro, Inc.
  • 37. Tempus Labs, Inc.
  • 38. Trialbee AB
  • 39. TrialHub by FindMeCure Ltd.
  • 40. Veeva Systems Inc.
  • 41. Worldwide Clinical Trials

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIALS MATCHING SOFTWARE MARKET MULTI-CURRENCY
  • FIGURE 2. CLINICAL TRIALS MATCHING SOFTWARE MARKET MULTI-LANGUAGE
  • FIGURE 3. CLINICAL TRIALS MATCHING SOFTWARE MARKET RESEARCH PROCESS
  • FIGURE 4. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CLINICAL TRIALS MATCHING SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CLINICAL TRIALS MATCHING SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIALS MATCHING SOFTWARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIALS MATCHING SOFTWARE MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY ANALYTICS & REPORTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COMPLIANCE TRACKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY PATIENT MATCHING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CLOUD & WEB BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY MEDICAL DEVICE FIRMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. CLINICAL TRIALS MATCHING SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. CLINICAL TRIALS MATCHING SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023